Dexcom G7 sensors provide continuous glucose monitoring for up to 10 days, with an additional 12-hour grace period to allow for flexibility in sensor replacement
This suggests that, at higher dose ranges, switching between agents may provide incremental benefit beyond within-drug dose escalation in selected patients
Research shows that most people regain significant weight when stopping GLP-1 medications if they do not maintain intensive lifestyle modifications
Conversely, diets rich in fruits, vegetables, whole grains, and lean proteins have been linked to better mental health outcomes
The New Study: A Three-Way Race for Oral Semaglutide This randomized, placebo-controlled study will compare three different semaglutide formulations, all at a 7mg dose: Rybelsus (control): A standard swallowed tablet with low absorption rates